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Background: Folate deﬁciency leads to DNA damage and inadequate repair, caused by a decreased synthesis of
thymidylate and purines. We analyzed the relationship between dietary folate intake and the risk of several cancers.
Patients and methods: The study is based on a network of case–control studies conducted in Italy and Switzerland
in 1991–2009. The odds ratios (ORs) for dietary folate intake were estimated by multiple logistic regression models,
adjusted for major identiﬁed confounding factors.
Results: For a few cancer sites, we found a signiﬁcant inverse relation, with ORs for an increment of 100 μg/day of
dietary folate of 0.65 for oropharyngeal (1467 cases), 0.58 for esophageal (505 cases), 0.83 for colorectal (2390 cases),
0.72 for pancreatic (326 cases), 0.67 for laryngeal (851 cases) and 0.87 for breast (3034 cases) cancers. The risk
estimates were below unity, although not signiﬁcantly, for cancers of the endometrium (OR = 0.87, 454 cases), ovary
(OR = 0.86, 1031 cases), prostate (OR = 0.91, 1468 cases) and kidney (OR = 0.88, 767 cases), and was 1.00 for
stomach cancer (230 cases). No material heterogeneity was found in strata of sex, age, smoking and alcohol drinking.
Conclusions: Our data support a real inverse association of dietary folate intake with the risk of several common
cancers.
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introduction
Folates, the water-soluble vitamin B9, play a central role as
cofactors in nucleotide synthesis and have been involved in
both prevention and promotion of cancer [1].
Many epidemiological studies have shown that dietary folate
intake is inversely related with cancer at several sites [2]. A
meta-analysis of 18 case–control studies of colorectal cancer
found an overall odds ratio (OR) for high versus low intake of
folates of 0.85 [95% conﬁdence interval (CI) 0.74–0.99] [3],
and a pooled analysis of 13 prospective studies found a relative
risk (RR) of colon cancer for highest versus lowest intake of
folate of 0.92 (95% CI 0.84–1.00) [4]. As for other cancers of
the digestive tract, a meta-analysis found overall RRs for the
highest versus the lowest intake of dietary folates of 0.66 (95%
CI 0.53–0.83) for esophageal squamous cell carcinoma (based
on four case–control studies), 0.50 (95% CI 0.39–0.65) for
esophageal adenocarcinoma (three case–control studies) and
0.90 (95% CI 0.72–1.13) for gastric cancer (two cohort and
*Correspondence to: Dr A. Tavani, Department of Epidemiology, Istituto di Ricerche
Farmacologiche ‘Mario Negri’, Via G. La Masa 19, 20156 Milan, Italy. Tel: +39-02-3901-
4722; Fax: +39-02-3320-0231; E-mail: alessandra.tavani@marionegri.it
Annals of Oncology original articles
© The Author 2012. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
All rights reserved. For permissions, please email: journals.permissions@oup.com.
nine case–control studies) [5]. For pancreatic cancer, a meta-
analysis (based on four cohort and one case–control studies)
found a RR of 0.49 (95% CI 0.35–0.67) [5]. This inverse
association with pancreatic cancer was recently conﬁrmed in an
American case–control study, with an OR for the highest quintile
of intake of 0.67 (95% CI 0.48–0.93) [6] compared to the lowest
one, but not in a large pooled analysis of 14 prospective studies
(RR = 1.06, 95% CI 0.90–1.25, for the highest quintile compared
to the lowest one) [7].
Data are scantier for oral and pharyngeal, and laryngeal
cancer. A case–control study conducted in Uruguay,
considering the risk of 11 types of cancer in relation to dietary
folate intake, found an OR for an increment of 100 μg/day of
0.56 (95% CI 0.37–0.83) for oral and pharyngeal and of 0.52
(95% CI 0.35–0.77) for laryngeal cancer [2].
The results are inconsistent for endometrial cancer, with two
cohort studies ﬁnding no relation [8, 9] and a case–control
study ﬁnding an inverse relation [10], and for ovarian cancer,
with one cohort study ﬁnding no relation [11] and two cohort
studies ﬁnding an inverse association with folate intake only in
women in the highest category of alcohol drinking [12, 13].
For breast cancer the evidence is inconsistent. A meta-
analysis, considering the relation of breast cancer risk with an
increments of 200 μg/day of dietary folates, found a null
relation in 8 prospective studies (RR = 0.97, 95% CI 0.88–1.07),
and an inverse association in 13 case-control studies
(OR = 0.80, 95% CI 0.72–0.89). In a meta-analysis of 6
prospective and 2 case–control studies of prostate cancer the
RR was 1.11 (95% CI 0.96–1.28) for an increase of plasmatic
concentration of 10 nmol/l) [15].
As the evidence is inconsistent for a few cancer sites, we
have analyzed the relation between dietary intake of folates and
the risk of cancers at selected sites using data from a network
of case–control studies, conducted in Italy and Switzerland.
This large dataset allowed adjustment for a large number of
covariates. Previous analyses of subsets of this dataset showed
signiﬁcant inverse associations between dietary folate intake
and cancers of oral cavity and pharynx [16], esophagus [17],
colorectum [18], pancreas [19] and prostate [20], and no
relation with cancers of the stomach [21], breast [22] and
ovary [23].
materials and methods
Between 1991 and 2009, we conducted an integrated series of case–control
studies on several neoplasms in various areas of northern (the greater
Milan area; the provinces of Pordenone, Padua, Udine, Gorizia and Forlì;
the urban area of Genoa), central (the provinces of Rome and Latina), and
southern (the urban area of Naples) Italy. We also conducted companion
studies on cancers of the oral cavity and pharynx, esophagus, colorectum,
larynx, breast and endometrium in the Canton of Vaud, Switzerland. The
present analysis includes a total of 1467 cases of cancer of the oral cavity
and pharynx [16, 24–26], 505 cases of cancer of the esophagus [17, 27–29],
230 of cancer of the stomach [30], 2390 of cancer of the colorectum [18,
31, 32], 851 of cancer of the larynx [33], 326 of cancer of the pancreas [34],
454 of cancer of the endometrium [35], 3034 of cancer of the breast [22,
36, 37], 1031 of cancer of the ovary [23, 38], 1468 of cancer of the prostate
[20, 39], 767 of cancer of the kidney [40] and a total of 22 828 controls
(Table 1).
All studies included incident cases identiﬁed in the major teaching and
general hospitals of the study areas. Controls were subjects admitted to the
same network of hospitals as cases for a wide spectrum of acute, non-
neoplastic conditions, unrelated to known risk factors for the
corresponding cancer site. Overall, 26% of controls were admitted for
traumatic conditions, 15% for nontraumatic orthopedic conditions, 27%
for acute surgical conditions and 32% for miscellaneous other illnesses.
Refusal to participation of subjects approached was <5% in Italy, and
was ∼15% in Switzerland. The study protocols were revised and approved
by the ethical committees of the hospitals involved, according to the
regulations at the time of each study conduction, and all participants gave
informed consent.
During their hospital stay, cases and controls were asked by centrally
trained interviewers to ﬁll a standard questionnaire, which included
personal and sociodemographic characteristics, anthropometric measures
and lifestyle habits (including tobacco smoking, alcohol consumption and
physical activity). A reproducible [41] and valid [42] food-frequency
questionnaire (FFQ) was used to assess the patients’ usual diet in the 2
years preceding diagnosis (for cases) or hospital admission (for controls).
The FFQ included the average weekly consumption of 78 food items or
food groups and beverages. Intakes lower than once per week, but at least
once per month, were coded as 0.5 per week. Energy and nutrient intake,
including folates, were computed using an Italian food composition
database [43].
statistical analysis
ORs and the corresponding 95% CI of various cancers according to
quartiles of intake of dietary folates, based on the distribution of controls,
were estimated using unconditional or conditional multiple logistic
regression models [44], depending on whether cases and controls for the
considered anatomical sites were matched or not. All models included
terms for sex (when appropriate), quinquennia of age, study center, year of
interview, education, alcohol drinking, tobacco smoking, body mass index,
total energy intake and physical activity at work. Stratiﬁcations for sex, age,
Table 1. Number of cases of selected cancer sites and controls, by sex and
median age
Cancer site Cases
(men/
women)
Median age
(years)
Controlsa
(men/
women)
Median age
(years)
Oral cavity and
pharynx
1190/277 58 2553/1208 58
Esophagus 438/67 60 919/340 60
Stomach 143/87 63 286/261 63
Colorectum 1401/989 62 2586/2357 58
Colon 835/628 62 2586/2357 58
Rectum 566/361 63 2586/2357 58
Pancreas 174/152 63 348/304 63
Larynx 770/81 62 1564/406 61
Breast –/3034 55 –/3392 56
Endometrium –/454 62 –/1366 61
Ovary –/1031 56 –/2411 57
Prostate 1468/– 66 1451/– 63
Kidney 494/273 62 988/546 61
Italy and Switzerland, 1991–2009.
aThe sum is higher than the total as some controls are common to more
cancer sites.
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tobacco smoking and alcohol drinking were performed for cancer sites
showing signiﬁcant association with the disease.
results
Table 2 shows the distribution of cancer cases and controls
according to quartile of dietary folate intake and the
corresponding ORs. The ORs for the highest quartile of intake
compared to the lowest one were signiﬁcantly below unity for
cancers of oral cavity and pharynx (OR = 0.37), esophagus
(OR = 0.26), colorectum (OR = 0.74) and larynx (OR = 0.55),
with a signiﬁcant trend in risk. The OR was of borderline
signiﬁcance for breast (OR = 0.82) and prostate cancer
(OR = 0.79), with a signiﬁcant trend in risk no relationship was
found for cancer of the stomach (OR = 1.59), pancreas
(OR = 0.74), endometrium (OR = 1.06), ovary (OR = 0.83) and
kidney (OR = 0.86).
The relation between an increment of 100 μg/day of folate
with diet and risk of cancer at investigated sites is reported in
Figure 1. There was a signiﬁcant inverse association for cancers
of the oral cavity and pharynx (OR = 0.65), esophagus
(OR = 0.58), colorectum (OR = 0.83), pancreas (OR = 0.72),
larynx (OR = 0.67) and breast (OR = 0.87). The risk estimates
were below unity, although not signiﬁcantly, for cancers of the
endometrium (OR = 0.87), ovary (OR = 0.86), prostate
(OR = 0.91) and kidney (OR = 0.88). The OR was 1.00 for
stomach cancer. Further adjustment for vegetable intake
generally weakened the inverse association, and the ORs for an
Table 2. Distribution of cases of selected cancer sites and controls, and corresponding odds ratio (OR) and 95% conﬁdence interval (CI), according to
quartiles of dietary folate intake
Cancer site Quartile of intakea χ2 trend, P
1st 2nd 3rd 4th
Oral cavity and pharynx
No. of cases : controls 394 : 940 313 : 940 365 : 941 395 : 940
ORb (95% CI) 1c 0.56 (0.43–0.74) 0.59 (0.44–0.77) 0.37 (0.26–0.51) <0.0001
Esophagus
No. of cases : controls 144 : 314 110 : 316 122 : 317 128 : 315
ORb (95% CI) 1c 0.63 (0.40–0.98) 0.45 (0.28–0.73) 0.26 (0.14–0.48) <0.0001
Stomach
No. of cases : controls 38 : 136 55 : 138 61 : 137 76 : 136
ORb (95% CI) 1c 1.26 (0.75–2.13) 1.29 (0.73–2.25) 1.59 (0.84–3.01) 0.1853
Colorectum
No. of cases : controls 587 : 1235 607 : 1236 555 : 1236 641 : 1236
ORb (95% CI) 1c 0.93 (0.80–1.08) 0.75 (0.64–0.88) 0.74 (0.61–0.90) 0.0004
Pancreas
No. of cases : controls 74 : 163 73 : 163 92 : 163 87 : 163
ORb (95% CI) 1c 0.79 (0.52–1.21) 0.96 (0.61–1.50) 0.74 (0.43–1.28) 0.4539
Larynx
No. of cases : controls 215 : 493 182 : 491 225 : 493 229 : 492
ORb (95% CI) 1c 0.71 (0.52–0.96) 0.80 (0.58–1.09) 0.55 (0.38–0.80) 0.0090
Breast
No. of cases : controls 644 : 848 757 : 848 836 : 848 797 : 848
ORb (95% CI) 1b 0.99 (0.84–1.16) 0.98 (0.82–1.16) 0.82 (0.65–1.03) 0.0098
Endometrium
No. of cases : controls 98 : 227 124 : 227 99 : 227 133 : 227
ORb (95% CI) 1c 1.10 (0.77–1.57) 0.79 (0.53–1.18) 1.06 (0.67–1.67) 0.7593
Ovary
No. of cases : controls 208 : 602 267 : 603 263 : 603 293 : 603
ORb (95% CI) 1c 0.95 (0.74–1.23) 0.85 (0.64–1.11) 0.83 (0.60–1.15) 0.2021
Prostate
No. of cases : controls 297 : 363 346 : 362 304 : 364 347 : 362
ORb (95% CI) 1c 0.98 (0.78–1.24) 0.82 (0.64–1.05) 0.79 (0.59–1.05) 0.0483
Kidney
No. of cases : controls 194 : 383 190 : 384 196 : 384 187 : 383
ORb (95% CI) 1c 0.94 (0.72–1.22) 0.94 (0.71–1.25) 0.86 (0.61–1.20) 0.4143
Italy and Switzerland, 1991–2009.
aMean values of upper cut-point were (μg/day): 208.77 for the ﬁrst quartile, 257.25 for the second quartile and 312.47 for the third quartile.
bEstimated from multiple logistic regression models adjusted for sex (when appropriate), age, study center, year of interview, education, alcohol drinking,
tobacco smoking, body mass index, total energy intake and physical activity at work.
cReference category.
Annals of Oncology original articles
Volume 23 | No. 10 | October 2012 doi:10.1093/annonc/mds212 | 
increment of 100 μg/day of folate with diet were 0.69 (95% CI
0.59–0.81) for oral and pharyngeal, 0.78 (95% CI 0.57–1.06)
for esophageal, 1.39 (95% CI 0.98–1.97) for stomach, 1.04
(95% CI 0.94–1.16) for colorectal, 0.72 (95% CI 0.53–0.98) for
pancreatic, 0.81 (95% CI 0.66–1.00) for laryngeal, 0.96 (95% CI
0.86–1.08) for breast, 0.76 (95% CI 0.56–1.03) for endometrial,
1.11 (95% CI 0.92–1.35) for ovarian, 1.05 (95% CI 0.88–1.23)
for prostatic and 1.07 (95% CI 0.87–1.31) for kidney cancer.
A stratiﬁed analysis by sex, age, tobacco smoking and
alcohol drinking for cancer sites showing an inverse relation
with dietary folate intake is shown in Table 3. There was no
material heterogeneity across strata of the selected covariates,
except for a slightly stronger inverse relation of folates with
breast cancer risk in women <60 years compared with older
ones.
discussion
We found an inverse association of dietary folate intake with
oral and pharyngeal, esophageal, colorectal, pancreatic,
laryngeal and breast cancers. The risk estimates were below
unity, although not signiﬁcantly, for cancers of the
endometrium, ovary, prostate and kidney. No relation was
found with stomach cancer.
The role of folates in the carcinogenic process is complex,
and probably includes both positive and negative aspects
depending on the dose [45]. It has been shown that folate
deﬁciency has an inhibitory effect on the progression of
colorectal adenomas and neoplasia, while folic acid excess
through supplementation may have a promoting effect [46].
Folate deﬁciency leads to DNA damage and inadequate
Figure 1 Dietary folate intake and risk of selected cancers. Black squares indicate the odds ratio (OR) and the horizontal lines represent 95% conﬁdence
interval (CI) for an increment of dietary folate intake of 100 μg/day.
Table 3. Odds ratio (OR)a and 95% conﬁdence interval (CI) for an increment of dietary folate intake of 100 μg/day in strata of selected covariates
Cancer site Sex Age (years) Smoking habit Alcohol drinking
Men Women <60 ≥60 Nonsmokers Current
smokers
Nondrinkers Current
drinkers
Oral cavity and
pharynx
0.66 (0.56–0.78) 0.62 (0.45–0.86) 0.70 (0.57–0.85) 0.60 (0.49–0.75) 0.63 (0.51–0.78) 0.65 (0.52–0.81) 0.65 (0.47–0.90) 0.63 (0.54–0.75)
Esophagus 0.53 (0.39–0.71) 0.96 (0.37–2.50) 0.60 (0.40–0.91) 0.51 (0.34–0.75) 0.73 (0.51–1.06) 0.38 (0.24–0.60) 0.62 (0.25–1.53) 0.52 (0.38–0.70)
Colorectum 0.78 (0.69–0.89) 0.89 (0.78–1.03) 0.84 (0.73–0.96) 0.83 (0.73–0.94) 0.82 (0.73–0.91) 0.86 (0.73–1.03) 0.73 (0.61–0.88) 0.86 (0.78–0.96)
Larynx 0.67 (0.55–0.81) 0.74 (0.39–1.41) 0.75 (0.57–0.99) 0.60 (0.46–0.77) 0.74 (0.58–0.95) 0.54 (0.40–0.72) 1.05 (0.63–1.73) 0.64 (0.52–0.78)
Breast – – 0.80 (0.71–0.89) 1.01 (0.86–1.18) 0.86 (0.78–0.96) 0.89 (0.74–1.08) 0.85 (0.74–0.98) 0.87 (0.77–0.98)
Prostate – – 0.95 (0.72–1.25) 0.89 (0.75–1.06) 0.94 (0.80–1.11) 0.84 (0.62–1.13) 0.71 (0.46–1.11) 0.93 (0.80–1.09)
Italy and Switzerland, 1991–2009.
aEstimate from multiple logistic regression models adjusted for sex (when appropriate), age, study center, year of interview, education, alcohol drinking,
tobacco smoking, body mass index, total energy intake and physical activity at work.
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repair, caused by a decreased synthesis of thymidylate and
purines [47], and genomic hypomethylation leading to
colonic neoplasia [48]. However, at supplementation doses,
folates may negatively inﬂuence epigenetic gene regulation
leading to cancer promotion [49], and two randomized
clinical trials of folic acid suggested a potential nonsigniﬁcant
increased risk of colon and prostate cancers [50], and a
potential increased risk of colorectal adenomas [51]. In our
study, we have no information on dietary supplementation,
which, however, is uncommon in Italy [20]; thus, our results
are related to dietary folates only.
In the Italian diet, folates derive approximately for 21% from
vegetables, for 25% from cereals and for the other 50% from all
other foods [52]. Thus, it is not easy to disentangle the effect of
folates from that of speciﬁc foods or other related nutrients or
food components [52], and folates cannot be considered a
general marker for a more favorable dietary pattern or
healthier lifestyle. Moreover, most inverse relations were
weakened but tended to persist after adjustment for vegetable
intake, further suggesting that folates cannot be merely
considered an indirect indicator of vegetable intake (one of the
major sources of folates in the Italian diet), but they may have
a real protective role on several cancers.
The inverse relation between folate intake and the risk of
several cancer sites was further supported by the observation
that the decreased risk was similar across strata of major
covariates. If not due to the multiple comparison and hence
the play of chance, the slightly weaker effect of folates on breast
cancer in older women may be related to metabolic differences
in the elderly.
Alcohol intake inhibits folate-mediated methionine synthesis
and may interrupt methylation processes mediated by
methionine (the substrate for biologic methylation), inducing
DNA hypomethylation in the intestinal mucosa [53]. Folate
intake has been reported to reduce the risk of ovarian cancer in
alcohol drinkers [11, 12]. However, in our dataset, we found no
appreciable modulation of alcohol intake on the relation
between folates and the risk of ovarian and the other cancers
considered [23].
Our data are in broad agreement with those of the
literature. We conﬁrmed the protective effect of dietary folate
on the risk of colorectal [3, 4], esophageal [5], oral and
pharyngeal [2] and laryngeal and the absence of consistent
relation with stomach cancer [5] found in other studies.
However, we did not conﬁrm the inverse association of
dietary folate intake with kidney cancer found in a case–
control study from Uruguay [2]. For pancreatic cancer, we
found an inverse association only when the OR was
calculated in continuous. This borderline inverse association
is in agreement with overall evidence based on a pooled
analysis of prospective studies ﬁnding no relation [7], and
on a meta-analysis [5] and a subsequent case–control study
[6] ﬁnding overall protection.
All studies included in the present analysis are hospital
based. However, selection bias should be limited as
participation of cases and controls was similar, and cases and
controls were identiﬁed in the major teaching and general
hospitals of the areas under surveillance. Moreover, we
excluded from the control group patients admitted to hospital
for chronic conditions or digestive tract diseases, which could
have affected dietary habits. In a reproducibility study, a
satisfactory comparability of dietary information was found
between subjects interviewed at home and in the hospital [54].
The similar interview setting for cases and controls provides
reassurance against potential information bias [54], and there
is also no reason to suspect different selective recall of food
intake on the basis of the disease status. The FFQ was
satisfactorily valid and reproducible [41, 42]. An indirect
support for a real inverse association between folate intake and
cancer at several sites comes from the consistent relation across
strata of age, sex, alcohol intake and tobacco smoking, and
from the absence of association for a few cancer sites, which
exclude a systematic bias due to study design. A major strength
of our study was the possibility to allow for several
confounding factors. However, residual confounding remains
possible, also given to the inﬂuence of other cofactors and
intake of other foods on folate absorption in the jejunum.
In conclusion, our data support a real inverse association
of folate dietary intake with the risk of several common
cancers.
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